Indivior Pharmaceuticals, Inc. · NASDAQ:INDV
Preblick Ryan sold 36,000 Indivior Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 8, 2026 · Filed Jun 10, 2026
On Jun 8, 2026, Preblick Ryan (Chief Financial Officer) sold 36,000 Indivior Pharmaceuticals, Inc. shares at US$37.70 for US$1.36M under a trading plan, leaving 284,751 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 36,000 shares
- Price
- US$37.70
- Value
- US$1.36M
- Holding after
- 284,751 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | Sale | 36,000 | US$37.70 | 284,751 | Direct |
Source
Related
- Indivior Pharmaceuticals, Inc.
- Preblick Ryan
- Indivior Pharmaceuticals, Inc. shareholders
- Schedule 13G · Millennium Management LLC · Sep 30, 2026
- Form 4 · Anderson Woodrow D · Aug 27, 2026
- Schedule 13D/A · Oaktree Capital Holdings, LLC · Aug 13, 2026
- Form 4 · Anderson Woodrow D · Aug 5, 2026
- Form 4 · Heidbreder Christian · Jul 13, 2026